Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Profiling changes in gait dynamics resulting from progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced nigrostriatal lesioning

Identifieur interne : 000182 ( Main/Exploration ); précédent : 000181; suivant : 000183

Profiling changes in gait dynamics resulting from progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced nigrostriatal lesioning

Auteurs : Natalie R. S. Goldberg [États-Unis] ; Tom Hampton [États-Unis] ; Scott Mccue [États-Unis] ; Ajit Kale [États-Unis] ; Charles K. Meshul [États-Unis]

Source :

RBID : ISTEX:467B3B517AC277FB280DB6D4774E7CC01222C515

English descriptors

Abstract

Current behavioral measurements for motor impairment are not consistently sensitive in rodent models of partial nigrostriatal dopamine (DA) depletion. In addition to exploratory and somatosensory behavior, motor skills that are thought to be directly translatable to human Parkinson's disease patients are assessed. However, many of these motor tests require the training and learning of particular tasks, so it cannot be determined whether impairments are due to motor or to learning deficit. Therefore, we have quantified multiple temporal and spatial indices of gait dynamics in a model of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced partial nigrostriatal lesioning using a treadmill apparatus requiring no prior training. Three days following the cessation of progressively increased MPTP administration, rearing and foot‐fault behaviors showed significant deficit. Ten days after the final MPTP injection, gait dynamics were assessed and indicated differences between MPTP‐ and vehicle‐treated animals. The major significant changes were in stride length, frequency, duration, and number of steps. Three weeks following a progressively increased dose of MPTP (administered 5 days per week over the course of 4 weeks), mice showed a 63% decrease in tyrosine hydroxylase‐immunoreactive (TH‐ir) nigrostriatal neurons in the substantia nigra pars compacta and a 72% decrease in TH‐ir terminals in the caudate‐putamen. This suggests that there is a continued effect of progressively increased MPTP on nigrostriatal DA neurons, correlated with rearing and foot‐fault behaviors and further characterized by differences in temporal and spatial measurements of gait dynamics. © 2011 Wiley‐Liss, Inc.

Url:
DOI: 10.1002/jnr.22699


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Profiling changes in gait dynamics resulting from progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced nigrostriatal lesioning</title>
<author>
<name sortKey="Goldberg, Natalie R S" sort="Goldberg, Natalie R S" uniqKey="Goldberg N" first="Natalie R. S." last="Goldberg">Natalie R. S. Goldberg</name>
</author>
<author>
<name sortKey="Hampton, Tom" sort="Hampton, Tom" uniqKey="Hampton T" first="Tom" last="Hampton">Tom Hampton</name>
</author>
<author>
<name sortKey="Mccue, Scott" sort="Mccue, Scott" uniqKey="Mccue S" first="Scott" last="Mccue">Scott Mccue</name>
</author>
<author>
<name sortKey="Kale, Ajit" sort="Kale, Ajit" uniqKey="Kale A" first="Ajit" last="Kale">Ajit Kale</name>
</author>
<author>
<name sortKey="Meshul, Charles K" sort="Meshul, Charles K" uniqKey="Meshul C" first="Charles K." last="Meshul">Charles K. Meshul</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:467B3B517AC277FB280DB6D4774E7CC01222C515</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/jnr.22699</idno>
<idno type="url">https://api.istex.fr/document/467B3B517AC277FB280DB6D4774E7CC01222C515/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001677</idno>
<idno type="wicri:Area/Main/Curation">001441</idno>
<idno type="wicri:Area/Main/Exploration">000182</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Profiling changes in gait dynamics resulting from progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced nigrostriatal lesioning</title>
<author>
<name sortKey="Goldberg, Natalie R S" sort="Goldberg, Natalie R S" uniqKey="Goldberg N" first="Natalie R. S." last="Goldberg">Natalie R. S. Goldberg</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Oregon</region>
</placeName>
<wicri:cityArea>VA Medical Center, Portland</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Hampton, Tom" sort="Hampton, Tom" uniqKey="Hampton T" first="Tom" last="Hampton">Tom Hampton</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Mouse Specifics, Quincy</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Mccue, Scott" sort="Mccue, Scott" uniqKey="Mccue S" first="Scott" last="Mccue">Scott Mccue</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Mouse Specifics, Quincy</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kale, Ajit" sort="Kale, Ajit" uniqKey="Kale A" first="Ajit" last="Kale">Ajit Kale</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
<wicri:cityArea>Mouse Specifics, Quincy</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Meshul, Charles K" sort="Meshul, Charles K" uniqKey="Meshul C" first="Charles K." last="Meshul">Charles K. Meshul</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Oregon</region>
</placeName>
<wicri:cityArea>VA Medical Center, Portland</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Oregon</region>
</placeName>
<wicri:cityArea>Department of Behavioral Neuroscience and Pathology, Oregon Health and Science University, Portland</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Neuroscience Research</title>
<title level="j" type="abbrev">J. Neurosci. Res.</title>
<idno type="ISSN">0360-4012</idno>
<idno type="eISSN">1097-4547</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-10">2011-10</date>
<biblScope unit="volume">89</biblScope>
<biblScope unit="issue">10</biblScope>
<biblScope unit="page" from="1698">1698</biblScope>
<biblScope unit="page" to="1706">1706</biblScope>
</imprint>
<idno type="ISSN">0360-4012</idno>
</series>
<idno type="istex">467B3B517AC277FB280DB6D4774E7CC01222C515</idno>
<idno type="DOI">10.1002/jnr.22699</idno>
<idno type="ArticleID">JNR22699</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0360-4012</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Parkinson's disease</term>
<term>dopamine</term>
<term>gait</term>
<term>progressive</term>
<term>tyrosine hydroxylase</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Current behavioral measurements for motor impairment are not consistently sensitive in rodent models of partial nigrostriatal dopamine (DA) depletion. In addition to exploratory and somatosensory behavior, motor skills that are thought to be directly translatable to human Parkinson's disease patients are assessed. However, many of these motor tests require the training and learning of particular tasks, so it cannot be determined whether impairments are due to motor or to learning deficit. Therefore, we have quantified multiple temporal and spatial indices of gait dynamics in a model of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced partial nigrostriatal lesioning using a treadmill apparatus requiring no prior training. Three days following the cessation of progressively increased MPTP administration, rearing and foot‐fault behaviors showed significant deficit. Ten days after the final MPTP injection, gait dynamics were assessed and indicated differences between MPTP‐ and vehicle‐treated animals. The major significant changes were in stride length, frequency, duration, and number of steps. Three weeks following a progressively increased dose of MPTP (administered 5 days per week over the course of 4 weeks), mice showed a 63% decrease in tyrosine hydroxylase‐immunoreactive (TH‐ir) nigrostriatal neurons in the substantia nigra pars compacta and a 72% decrease in TH‐ir terminals in the caudate‐putamen. This suggests that there is a continued effect of progressively increased MPTP on nigrostriatal DA neurons, correlated with rearing and foot‐fault behaviors and further characterized by differences in temporal and spatial measurements of gait dynamics. © 2011 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Massachusetts</li>
<li>Oregon</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Oregon">
<name sortKey="Goldberg, Natalie R S" sort="Goldberg, Natalie R S" uniqKey="Goldberg N" first="Natalie R. S." last="Goldberg">Natalie R. S. Goldberg</name>
</region>
<name sortKey="Hampton, Tom" sort="Hampton, Tom" uniqKey="Hampton T" first="Tom" last="Hampton">Tom Hampton</name>
<name sortKey="Kale, Ajit" sort="Kale, Ajit" uniqKey="Kale A" first="Ajit" last="Kale">Ajit Kale</name>
<name sortKey="Mccue, Scott" sort="Mccue, Scott" uniqKey="Mccue S" first="Scott" last="Mccue">Scott Mccue</name>
<name sortKey="Meshul, Charles K" sort="Meshul, Charles K" uniqKey="Meshul C" first="Charles K." last="Meshul">Charles K. Meshul</name>
<name sortKey="Meshul, Charles K" sort="Meshul, Charles K" uniqKey="Meshul C" first="Charles K." last="Meshul">Charles K. Meshul</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000182 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000182 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:467B3B517AC277FB280DB6D4774E7CC01222C515
   |texte=   Profiling changes in gait dynamics resulting from progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced nigrostriatal lesioning
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024